Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 44,421,450 | 0 | 45,454,710 | 42,803,670 | 39,442,860 |
| Cost of Goods | 11,556,340 | N/A | 10,639,310 | 9,233,430 | 8,675,240 |
| Gross Profit | 32,865,100 | 33,273,130 | 34,815,390 | 33,570,240 | 30,767,610 |
| Operating Expenses | 19,672,730 | 6,828,250 | 20,572,580 | 19,746,330 | 18,913,140 |
| Operating Income | 13,192,720 | -6,828,250 | 14,243,130 | 13,824,340 | 11,854,720 |
| Other Income | -836,210 | 0 | 668,320 | 549,210 | 404,250 |
| Pre-tax Income | 12,356,510 | -6,828,250 | 14,911,450 | 14,373,550 | 12,258,970 |
| Income Tax | 3,479,420 | N/A | 4,286,140 | 4,240,740 | 3,489,030 |
| Net Income Continuous | 9,839,178 | 9,841,238 | 10,619,000 | 10,132,810 | 8,729,482 |
| Net Income | $8,877,080 | $9,841,238 | $10,433,210 | $10,132,810 | $8,769,930 |
| EPS Basic Total Ops | 4.28 | 4.01 | 2.34 | 2.20 | 3.74 |
| EPS Basic Continuous Ops | 4.74 | 4.74 | 2.34 | 2.20 | 3.74 |
| EPS Diluted Total Ops | 4.23 | 4.01 | 2.34 | 2.20 | 3.73 |
| EPS Diluted Continuous Ops | 4.74 | 4.74 | 2.34 | 2.20 | 3.74 |
| EBITDA(a) | $15,182,970 | $-3,965,990 | $14,243,130 | $15,589,930 | $11,854,720 |